Serum BCMA to Determine Disease Progression in RRMM Patients
Sponsor: Incyte
Protocol Number: I-RUX-19-52
Start Date: Protocol in development
Not active
(Link not available as study is not submitted to FDA. Probable submission on mid November 2020)